Workplace Indirect Cost Impacts of Nasal and Sinus Symptoms and Related Conditions.


Journal

Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 18 6 2019
medline: 15 12 2020
entrez: 18 6 2019
Statut: ppublish

Résumé

Evaluate associations of nasal and sinus and related symptoms, as well as selected health conditions which produce those symptoms, with total lost productive time (LPT) at work in the past 2 weeks. We used a cross-sectional analysis of 2402 currently working subjects. Self-reported physician diagnoses, condition statuses measured with standardized instruments, and symptom-based factor scores from an exploratory factor analysis were used in survey weighted log-binomial regression. Pain and pressure, nasal blockage and discharge, and asthma and constitutional symptom factor scores as well as self-reported allergic rhinitis were associated with higher total LPT. Individuals who met operationalized criteria for multiple health conditions, especially chronic rhinosinusitis, had the greatest total LPT. Better management of these symptoms, and awareness of how they impact an individual's ability to perform job-functions in the workplace, could improve overall productivity.

Identifiants

pubmed: 31205204
doi: 10.1097/JOM.0000000000001636
pmc: PMC6766754
mid: NIHMS1051913
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e333-e339

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI106683
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137174
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008428
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI106683
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI145818
Pays : United States

Références

Biometrics. 1999 Jun;55(2):652-9
pubmed: 11318229
J Clin Epidemiol. 2001 Jun;54(6):610-8
pubmed: 11377122
Am J Rhinol. 2003 Jan-Feb;17(1):27-32
pubmed: 12693653
Neurology. 2003 Aug 12;61(3):375-82
pubmed: 12913201
J Occup Environ Med. 2003 Dec;45(12):1234-46
pubmed: 14665809
J Occup Environ Med. 2004 Apr;46(4):398-412
pubmed: 15076658
J Occup Environ Med. 2007 Jan;49(1):1-10
pubmed: 17215708
J Occup Environ Med. 2008 Jul;50(7):736-45
pubmed: 18617829
J Occup Environ Med. 2011 Oct;53(10):1161-71
pubmed: 21912277
Rhinology. 2011 Oct;49(4):420-8
pubmed: 21991567
Rhinol Suppl. 2012 Mar;23:3 p preceding table of contents, 1-298
pubmed: 22764607
Epidemiol Infect. 2013 Jun;141(6):1166-79
pubmed: 22929058
J Allergy Clin Immunol. 2013 May;131(5):1350-60
pubmed: 23541327
JAMA Intern Med. 2013 Nov 25;173(21):1980-90
pubmed: 24043228
Chest. 2014 Apr;145(4):787-793
pubmed: 24337140
Laryngoscope. 2014 Sep;124(9):2007-12
pubmed: 24619604
Clin Mol Hepatol. 2014 Dec;20(4):327-37
pubmed: 25548737
Laryngoscope. 2015 Jul;125(7):1547-56
pubmed: 25640115
Allergy. 2015 Dec;70(12):1613-21
pubmed: 26332371
Laryngoscope. 2016 Mar;126(3):570-4
pubmed: 26371457
Headache. 2016 Feb;56(2):306-22
pubmed: 26833083
Int Forum Allergy Rhinol. 2016 Feb;6 Suppl 1:S22-209
pubmed: 26889651
Int Forum Allergy Rhinol. 2017 Jan;7(1):50-55
pubmed: 27552523
Allergy. 2017 Feb;72(2):274-281
pubmed: 27590749
Laryngoscope. 2017 Aug;127(8):1742-1745
pubmed: 28295361
Curr Allergy Asthma Rep. 2017 Apr;17(4):20
pubmed: 28337570
Laryngoscope. 2018 Jan;128(1):23-30
pubmed: 28600803
Rhinology. 2017 Sep 1;55(3):251-261
pubmed: 28624844
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1274-1286.e9
pubmed: 29017832
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1327-1335.e3
pubmed: 29133225
Allergy. 2018 Jun;73(6):1244-1253
pubmed: 29331046
Int Forum Allergy Rhinol. 2018 Apr 12;:null
pubmed: 29645354
Clin Exp Allergy. 2018 Jun;48(6):650-662
pubmed: 29676834
Allergy. 2018 Aug;73(8):1715-1723
pubmed: 29729111
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716

Auteurs

Jordan R Kuiper (JR)

Department of Environmental Health and Engineering (Mr Kuiper, Dr Hirsch, Dr Schwartz); Department of Epidemiology and Health Services Research, Geisinger, Danville, Pennsylvania (Dr Hirsch, Dr Sundaresan, Dr Schwartz); Department of Biostatistics (Dr Bandeen-Roche), Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Otolaryngology Head and Neck Surgery (Dr Tan, Dr Kern, Dr Schleimer); and Division of Allergy and Immunology, Department of Medicine (Dr Tan, Dr Kern, Dr Schleimer), Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH